North America Continuous Glucose Monitoring Device Market

North America Continuous Glucose Monitoring Device Market By Component (Sensors, Transmitters, and Receivers) By End User (Hospitals, Homecare Settings and Other End Users) By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-4072 Publication Date: May-2020 Number of Pages: 76
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Continuous Glucose Monitoring Device Market, by Component
1.4.2 North America Continuous Glucose Monitoring Device Market, by End User
1.4.3 North America Continuous Glucose Monitoring Device Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Continuous Glucose Monitoring Device Market by Component
3.1 North America Sensors Market by Country
3.2 North America Transmitters Market by Country
3.3 North America Receivers Market by Country

Chapter 4. North America Continuous Glucose Monitoring Device Market by End-user
4.1 North America Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 North America Homecare Settings Market by Country
4.3 North America Other End Users Market by Country

Chapter 5. North America Continuous Glucose Monitoring Device Market by Country
5.1 US Continuous Glucose Monitoring Device Market
5.1.1 US Continuous Glucose Monitoring Device Market by Component
5.1.2 US Continuous Glucose Monitoring Device Market by End-user
5.2 Canada Continuous Glucose Monitoring Device Market
5.2.1 Canada Continuous Glucose Monitoring Device Market by Component
5.2.2 Canada Continuous Glucose Monitoring Device Market by End-user
5.3 Mexico Continuous Glucose Monitoring Device Market
5.3.1 Mexico Continuous Glucose Monitoring Device Market by Component
5.3.2 Mexico Continuous Glucose Monitoring Device Market by End-user
5.4 Rest of North America Continuous Glucose Monitoring Device Market
5.4.1 Rest of North America Continuous Glucose Monitoring Device Market by Component
5.4.2 Rest of North America Continuous Glucose Monitoring Device Market by End-user

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental & Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals:
6.6 Ypsomed AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 GlySens, Incorporated
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
6.10.1 Company Overview
6.11 Johnson and Johnson
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Segmental &Regional Analysis
6.11.4 Research & Development Expenses
6.11.5 Recent strategies and developments:
6.11.5.1 Approvals:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo